-$0.30 Earnings Per Share Expected for Inspire Medical Systems (INSP) This Quarter
Brokerages expect that Inspire Medical Systems (NASDAQ:INSP) will post earnings per share (EPS) of ($0.30) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Inspire Medical Systems’ earnings. The lowest EPS estimate is ($0.31) and the highest is ($0.29). The company is expected to issue its next earnings report on Tuesday, February 5th.
On average, analysts expect that Inspire Medical Systems will report full-year earnings of ($6.01) per share for the current fiscal year. For the next fiscal year, analysts forecast that the firm will report earnings of ($1.36) per share, with EPS estimates ranging from ($1.48) to ($1.28). Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Inspire Medical Systems.
Inspire Medical Systems (NASDAQ:INSP) last released its quarterly earnings results on Tuesday, November 6th. The company reported ($0.22) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.13. The company had revenue of $13.10 million during the quarter, compared to analyst estimates of $12.86 million. During the same period last year, the firm earned ($3.42) earnings per share. The business’s revenue was up 79.9% compared to the same quarter last year.
In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 15,000 shares of the firm’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $39.89, for a total transaction of $598,350.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Randy Ban sold 10,000 shares of Inspire Medical Systems stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $40.37, for a total value of $403,700.00. The disclosure for this sale can be found here.
Hedge funds have recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA acquired a new stake in Inspire Medical Systems during the second quarter valued at approximately $4,457,000. Gilder Gagnon Howe & Co. LLC bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $5,010,000. Jennison Associates LLC bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $3,185,000. Wasatch Advisors Inc. bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $1,065,000. Finally, Sei Investments Co. acquired a new position in shares of Inspire Medical Systems in the 2nd quarter valued at $1,093,000.
Inspire Medical Systems stock traded down $2.65 during trading on Friday, hitting $41.07. The company’s stock had a trading volume of 306,386 shares, compared to its average volume of 190,501. Inspire Medical Systems has a 1-year low of $22.50 and a 1-year high of $57.87.
Inspire Medical Systems Company Profile
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.